Cosmetics · Quasi-drug actives

Tranexamic Acid

トラネキサム酸 (Toranekisamu-san)

Also known as: TXA

At a glance

CategoryCosmetics
INCI nameTranexamic Acid
Japanese labeling nameトラネキサム酸
Common Japanese notationsトラネキサム酸
CAS number1197-18-8
OriginSynthetic (developed in Japan)
Typical functionsQuasi-drug whitening active (cosmetic context), Pharmaceutical use (separate context, antifibrinolytic)
Regulatory status in JapanApproved as a quasi-drug (医薬部外品) whitening active by MHLW. Pharmaceutical use is regulated separately.

Tranexamic acid is a synthetic lysine analog originally developed in 1962 by Shosuke and Utako Okamoto at Keio University in Japan as an antifibrinolytic pharmaceutical. In cosmetic use, the compound is approved as a quasi-drug whitening active in Japan, where it is positioned around interrupting inflammation-related contributors to hyperpigmentation. The pharmaceutical use and cosmetic use are entirely separately regulated.

Classification

Tags below link to other ingredients sharing the same attribute, so you can pivot from one ingredient to its peers.

Used in (typical product categories)

Finished-product categories that commonly include this ingredient in Japanese-market formulations.

  • Medicated whitening products (薬用美白)
  • Spot-care treatment products
  • Pharmaceutical applications (separate context)

What it is

Tranexamic acid is the synthetic lysine analog 4-(aminomethyl)cyclohexane-1-carboxylic acid. In medicinal use it functions as an antifibrinolytic; in cosmetic use it is positioned around skin tone uniformity and pigment-related concerns.

Typical uses in Japanese products

In Japanese cosmetics, tranexamic acid appears in medicated whitening products, often in serum and lotion formats.

Regulatory classification in Japan

Approved as a quasi-drug whitening active by MHLW. Pharmaceutical applications are separately regulated under prescription frameworks.

Regulatory classification in other markets

EUListed in CosIng. Permitted for cosmetic use within applicable concentration ranges.
USAINCI recognized for cosmetic use.
ChinaPermitted per IECIC listings.
KoreaPermitted under KFDA / MFDS for cosmetic use.

Example products

Example finished products will be added after each product's current full ingredient list has been verified.

All brand names and product names referenced anywhere on this site are the property of their respective owners. Example entries are provided for informational purposes only and do not imply endorsement.

Related ingredients

References

  1. Japan PMDA — quasi-drug active ingredient approval registry

Last updated: 2026-04-22. Ingredient entries are reviewed at least annually against current regulatory listings.

Explore more Japan-market resources

Related tools for overseas buyers, formulators, and sourcing teams.